Published in Blood Weekly, February 7th, 2002
Australian researchers administered the drug rtPA to patients up to six hours after their strokes and observed that brain damage was reduced and recovery enhanced.
"This research shows that although rtPA is not for everybody suffering from a stroke more than three hours old, it may work for those who have a large area of brain that is threatened but not yet permanently damaged by the stroke," said Steven Warach, MD, PhD, of the National Institute of Neurological Disorders and Stroke in Bethesda,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.